ArticleOncotarget2017

Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway.

Weilong Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.